Terezia Prikrylova

Terezia is the Chief Operating Officer of Hemispherian. She joined Hemispherian in 2019 after completing her PhD at Oslo University Hospital (OUHS).

Terezia discovered the cytotoxic effect of the drug candidates advanced by Hemispherian, while working in Adam’s scientific laboratory at OUHS. Her findings were published in Nature Scientific Reports, with her being the lead author.